Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide rarely causes liver toxicity in prostate cancer patients.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

All three treatments reduce hirsutism, but spironolactone works best long-term.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Hair loss from genetics and hormones can be treated with drugs or surgery.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.